Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
OCRA’s Rivkin Ovarian Cancer Research Symposium Convenes A Scientific Community Ready to Accelerate Progress
Researchers, clinicians, and advocates gather to share findings and build collaborations More than 375 researchers, clinicians, and advocates from across the ovarian cancer community gathered in Philadelphia for the 16th Biennial Rivkin Ovarian Cancer Research Symposium, presented for the first time by Ovarian Cancer Research Alliance (OCRA), from October 16-18. Founded in 1996 by the … Continued
“Nobody Wants This” Star Jackie Tohn Plays for OCRA on Who Wants To Be A Millionaire
Actress and comedian Jackie Tohn, known for playing Esther Roklov on Netflix’s Nobody Wants This, and a fan favorite from American Idol and GLOW, stepped into the hot seat on Who Wants To Be A Millionaire hosted by Jimmy Kimmel to play on behalf of Ovarian Cancer Research Alliance (OCRA), ultimately winning $125,000 to support … Continued
Action Alert: Urge Congress to Support the Ovarian Cancer IMPACT Act
After months of dedicated advocacy alongside survivors, families, and clinicians, the bipartisan Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act has officially been introduced in Congress. Championed by Senators Elissa Slotkin (D-MI) and Katie Britt (R-AL) in the Senate, and Representatives Rosa DeLauro (D-CT-03) and Don Bacon (R-NE-01) in the House, this bill … Continued